Prudential Financial’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
Other funds holding VTVT
SL
BBA
Prudential Financial's VTVT Position: Q3 2026 in Review
Prudential Financial opened a new position in vTv Therapeutics (VTVT) in Q3 2026: 12,218 shares worth $377K. The stake represents ﹤0.01% of the portfolio and ranks #2077 among its holdings. This is a return to the name: Prudential Financial previously reported a position in VTVT as recently as Q4 2022.
Prudential Financial first reported a position in VTVT in Q2 2022 and has held it in 4 quarters since. 38 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.
- Prudential Financial held 12,218 shares of vTv Therapeutics worth $377K as of Q3 2026.
- vTv Therapeutics was a new Prudential Financial position in Q3 2026.
- vTv Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2077 holding.
- Prudential Financial first reported a position in vTv Therapeutics in Q2 2022 and has held it in 4 quarters since.
- 38 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.